Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 05-Mar-24 4:22 PM View:  | Tanguler Tolga EVP, Chief Commercial Officer | Alnylam Pharmaceuticals Inc. (ALNY) | 01-Mar-24 | Grant | 4,751 | -- | -- | 91% 5.24K to 9.99K | |
| 05-Mar-24 4:21 PM View: | Garg Pushkal CMO & EVP Dev & Med Affairs | Alnylam Pharmaceuticals Inc. (ALNY) | 01-Mar-24 | Grant | 4,751 | -- | -- | 51% 9.35K to 14.1K | |
| 05-Mar-24 4:21 PM View: | Poulton Jeffrey V. EVP, Chief Financial Officer | Alnylam Pharmaceuticals Inc. (ALNY) | 01-Mar-24 | Grant | 7,741 | -- | -- | 40% 19.54K to 27.28K | |
| 05-Mar-24 4:20 PM View: | Greenstreet Yvonne Chief Executive Officer Director | Alnylam Pharmaceuticals Inc. (ALNY) | 01-Mar-24 | Grant | 23,754 | -- | -- | 49% 48.53K to 72.29K | |
| 01-Mar-24 4:12 PM View: | Sharp Philip A Director | Alnylam Pharmaceuticals Inc. (ALNY) | 29-Feb-24 | Option Exercise | 30,000 | $59.25 | $1,777,500.00 | 11% 266.9K to 296.9K | |
| 01-Mar-24 4:12 PM View: | Sharp Philip A Director | Alnylam Pharmaceuticals Inc. (ALNY) | 29-Feb-24 | Planned Option Sale | 30,000 | $151.34 | $4,540,070.00 | (10%) 296.9K to 266.9K | |
| 29-Feb-24 4:18 PM View: | Tanguler Tolga EVP, Chief Commercial Officer | Alnylam Pharmaceuticals Inc. (ALNY) | 28-Feb-24 | Option Sale | 501 | $155.30 | $77,805.40 | (9%) 5.74K to 5.24K | |
| 29-Feb-24 4:17 PM View: | Garg Pushkal CMO & EVP Dev & Med Affairs | Alnylam Pharmaceuticals Inc. (ALNY) | 28-Feb-24 | Option Sale | 574 | $155.30 | $89,144.60 | (6%) 9.92K to 9.35K | |
| 29-Feb-24 4:18 PM View: | Poulton Jeffrey V. EVP, Chief Financial Officer | Alnylam Pharmaceuticals Inc. (ALNY) | 28-Feb-24 | Option Sale | 574 | $155.30 | $89,144.60 | (3%) 20.11K to 19.54K | |
| 29-Feb-24 4:16 PM View: | Franchini Indrani Lall EVP, CLO & Secretary | Alnylam Pharmaceuticals Inc. (ALNY) | 28-Feb-24 | Option Sale | 329 | $155.30 | $51,094.50 | (7%) 4.46K to 4.13K | |
| 29-Feb-24 4:18 PM View: | Greenstreet Yvonne Chief Executive Officer Director | Alnylam Pharmaceuticals Inc. (ALNY) | 28-Feb-24 | Option Sale | 2,932 | $155.31 | $455,357.00 | (6%) 51.47K to 48.53K | |
| 29-Feb-24 4:16 PM View: | Franchini Indrani Lall EVP, CLO & Secretary | Alnylam Pharmaceuticals Inc. (ALNY) | 27-Feb-24 | Option Exercise | 878 | -- | -- | 24% 3.58K to 4.46K | |
| 29-Feb-24 4:18 PM View: | Greenstreet Yvonne Chief Executive Officer Director | Alnylam Pharmaceuticals Inc. (ALNY) | 27-Feb-24 | Option Exercise | 5,921 | -- | -- | 13% 45.55K to 51.47K | |
| 29-Feb-24 4:18 PM View: | Tanguler Tolga EVP, Chief Commercial Officer | Alnylam Pharmaceuticals Inc. (ALNY) | 27-Feb-24 | Option Exercise | 1,667 | -- | -- | 41% 4.07K to 5.74K | |
| 29-Feb-24 4:17 PM View: | Garg Pushkal CMO & EVP Dev & Med Affairs | Alnylam Pharmaceuticals Inc. (ALNY) | 27-Feb-24 | Option Exercise | 1,908 | -- | -- | 24% 8.01K to 9.92K | |
| 29-Feb-24 4:18 PM View: | Poulton Jeffrey V. EVP, Chief Financial Officer | Alnylam Pharmaceuticals Inc. (ALNY) | 27-Feb-24 | Option Exercise | 1,908 | -- | -- | 10% 18.2K to 20.11K | |
| 20-Feb-24 4:08 PM View: | Tanguler Tolga EVP, Chief Commercial Officer | Alnylam Pharmaceuticals Inc. (ALNY) | 16-Feb-24 | Sale | 1,009 | $148.06 | $149,397.00 | (20%) 5.08K to 4.07K | |
| 20-Feb-24 4:09 PM View: | Garg Pushkal CMO & EVP Dev & Med Affairs | Alnylam Pharmaceuticals Inc. (ALNY) | 16-Feb-24 | Sale | 1,308 | $148.06 | $193,666.00 | (14%) 9.32K to 8.01K | |
| 20-Feb-24 4:08 PM View: | Poulton Jeffrey V. EVP, Chief Financial Officer | Alnylam Pharmaceuticals Inc. (ALNY) | 16-Feb-24 | Sale | 1,007 | $148.06 | $149,099.00 | (5%) 19.21K to 18.2K | |
| 20-Feb-24 4:07 PM View: | Greenstreet Yvonne Chief Executive Officer Director | Alnylam Pharmaceuticals Inc. (ALNY) | 16-Feb-24 | Sale | 7,030 | $148.06 | $1,040,880.00 | (13%) 52.58K to 45.55K | |
| 20-Feb-24 4:08 PM View: | Tanguler Tolga EVP, Chief Commercial Officer | Alnylam Pharmaceuticals Inc. (ALNY) | 15-Feb-24 | Grant | 3,278 | -- | -- | 182% 1.8K to 5.08K | |
| 20-Feb-24 4:09 PM View: | Garg Pushkal CMO & EVP Dev & Med Affairs | Alnylam Pharmaceuticals Inc. (ALNY) | 15-Feb-24 | Grant | 4,295 | -- | -- | 85% 5.03K to 9.32K | |
| 20-Feb-24 4:08 PM View: | Poulton Jeffrey V. EVP, Chief Financial Officer | Alnylam Pharmaceuticals Inc. (ALNY) | 15-Feb-24 | Grant | 3,278 | -- | -- | 21% 15.93K to 19.21K | |
| 20-Feb-24 4:07 PM View: | Greenstreet Yvonne Chief Executive Officer Director | Alnylam Pharmaceuticals Inc. (ALNY) | 15-Feb-24 | Grant | 16,953 | -- | -- | 48% 35.62K to 52.58K | |
| 05-Feb-24 4:05 PM View: | Franchini Indrani Lall EVP, CLO & Secretary | Alnylam Pharmaceuticals Inc. (ALNY) | 02-Feb-24 | Option Sale | 1,591 | $170.99 | $272,050.00 | (31%) 5.17K to 3.58K | |
| 05-Feb-24 4:05 PM View: | Franchini Indrani Lall EVP, CLO & Secretary | Alnylam Pharmaceuticals Inc. (ALNY) | 01-Feb-24 | Option Exercise | 5,175 | -- | -- | 100% 0 to 5.17K | |
| 29-Dec-23 4:03 PM View: | Bonney Michael W Director | Alnylam Pharmaceuticals Inc. (ALNY) | 27-Dec-23 | Planned Option Sale | 30,000 | $195.00 | $5,850,000.00 | (60%) 50.03K to 20.03K | |
| 29-Dec-23 4:03 PM View: | Bonney Michael W Director | Alnylam Pharmaceuticals Inc. (ALNY) | 27-Dec-23 | Option Exercise | 30,000 | $96.45 | $2,893,500.00 | 150% 20.03K to 50.03K | |
| 07-Aug-23 6:05 PM View: | Garg Pushkal CMO & EVP Dev & Med Affairs | Alnylam Pharmaceuticals Inc. (ALNY) | 07-Aug-23 | Sale (Planned) | 4,166 | $183.89 | $766,083.00 | (45%) 9.19K to 5.03K | |
| 07-Aug-23 6:04 PM View: | Vaishnaw Akshay President | Alnylam Pharmaceuticals Inc. (ALNY) | 04-Aug-23 | Sale | 4,057 | $185.85 | $753,986.00 | (15%) 27.35K to 23.29K | |
| 07-Aug-23 6:04 PM View: | Greenstreet Yvonne Chief Executive Officer Director | Alnylam Pharmaceuticals Inc. (ALNY) | 04-Aug-23 | Sale | 4,057 | $185.85 | $753,986.00 | (10%) 39.68K to 35.62K | |
| 07-Aug-23 6:05 PM View: | Garg Pushkal CMO & EVP Dev & Med Affairs | Alnylam Pharmaceuticals Inc. (ALNY) | 04-Aug-23 | Sale | 3,461 | $185.85 | $643,223.00 | (27%) 12.65K to 9.19K | |
| 07-Aug-23 6:05 PM View: | Poulton Jeffrey V. EVP, Chief Financial Officer | Alnylam Pharmaceuticals Inc. (ALNY) | 04-Aug-23 | Sale | 3,460 | $185.85 | $643,037.00 | (18%) 19.39K to 15.93K | |
| 07-Aug-23 6:05 PM View: | Poulton Jeffrey V. EVP, Chief Financial Officer | Alnylam Pharmaceuticals Inc. (ALNY) | 03-Aug-23 | Grant | 7,627 | -- | -- | 65% 11.76K to 19.39K | |
| 04-Aug-23 4:02 PM View: | Bonney Michael W Director | Alnylam Pharmaceuticals Inc. (ALNY) | 03-Aug-23 | Option Sale | 6,448 | $185.38 | $1,195,310.00 | (24%) 26.48K to 20.03K | |
| 07-Aug-23 6:05 PM View: | Garg Pushkal CMO & EVP Dev & Med Affairs | Alnylam Pharmaceuticals Inc. (ALNY) | 03-Aug-23 | Grant | 7,627 | -- | -- | 152% 5.03K to 12.65K | |
| 07-Aug-23 6:04 PM View: | Vaishnaw Akshay President | Alnylam Pharmaceuticals Inc. (ALNY) | 03-Aug-23 | Grant | 8,941 | -- | -- | 49% 18.41K to 27.35K | |
| 07-Aug-23 6:04 PM View: | Greenstreet Yvonne Chief Executive Officer Director | Alnylam Pharmaceuticals Inc. (ALNY) | 03-Aug-23 | Grant | 8,941 | -- | -- | 29% 30.74K to 39.68K | |
| 04-Aug-23 4:02 PM View: | Bonney Michael W Director | Alnylam Pharmaceuticals Inc. (ALNY) | 02-Aug-23 | Option Exercise | 22,477 | -- | -- | 562% 4.0K to 26.48K | |
| 28-Apr-23 5:54 PM View: | Garg Pushkal CMO & EVP Dev & Med Affairs | Alnylam Pharmaceuticals Inc. (ALNY) | 28-Apr-23 | Sale (Planned) | 2,455 | $199.02 | $488,595.00 | (33%) 7.48K to 5.03K | |
| 28-Apr-23 5:55 PM View: | Poulton Jeffrey V. EVP, Chief Financial Officer | Alnylam Pharmaceuticals Inc. (ALNY) | 27-Apr-23 | Sale | 977 | $194.59 | $190,113.00 | (8%) 12.74K to 11.76K | |
| 28-Apr-23 5:55 PM View: | Tanguler Tolga EVP, Chief Commercial Officer | Alnylam Pharmaceuticals Inc. (ALNY) | 27-Apr-23 | Sale | 1,476 | $194.59 | $287,215.00 | (45%) 3.28K to 1.8K | |
| 28-Apr-23 5:54 PM View: | Garg Pushkal CMO & EVP Dev & Med Affairs | Alnylam Pharmaceuticals Inc. (ALNY) | 27-Apr-23 | Sale | 1,839 | $194.59 | $357,855.00 | (20%) 9.32K to 7.48K | |
| 28-Apr-23 5:54 PM View: | Vaishnaw Akshay President | Alnylam Pharmaceuticals Inc. (ALNY) | 27-Apr-23 | Sale | 2,392 | $194.59 | $465,464.00 | (12%) 20.8K to 18.41K | |
| 28-Apr-23 5:55 PM View: | Greenstreet Yvonne Chief Executive Officer Director | Alnylam Pharmaceuticals Inc. (ALNY) | 27-Apr-23 | Sale | 7,615 | $194.59 | $1,481,810.00 | (20%) 38.35K to 30.74K | |
| 28-Apr-23 5:54 PM View: | Garg Pushkal CMO & EVP Dev & Med Affairs | Alnylam Pharmaceuticals Inc. (ALNY) | 26-Apr-23 | Grant | 4,294 | -- | -- | 85% 5.03K to 9.32K | |
| 28-Apr-23 5:54 PM View: | Vaishnaw Akshay President | Alnylam Pharmaceuticals Inc. (ALNY) | 26-Apr-23 | Grant | 5,312 | -- | -- | 34% 15.48K to 20.8K | |
| 28-Apr-23 5:55 PM View: | Greenstreet Yvonne Chief Executive Officer Director | Alnylam Pharmaceuticals Inc. (ALNY) | 26-Apr-23 | Grant | 16,952 | -- | -- | 79% 21.4K to 38.35K | |
| 28-Apr-23 5:55 PM View: | Tanguler Tolga EVP, Chief Commercial Officer | Alnylam Pharmaceuticals Inc. (ALNY) | 26-Apr-23 | Grant | 3,277 | -- | -- | 100% 0 to 3.28K | |
| 28-Apr-23 5:55 PM View: | Poulton Jeffrey V. EVP, Chief Financial Officer | Alnylam Pharmaceuticals Inc. (ALNY) | 26-Apr-23 | Grant | 3,277 | -- | -- | 35% 9.46K to 12.74K |
